BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6870623)

  • 1. Aminocaproic acid decreases secondary hemorrhage after traumatic hyphema.
    McGetrick JJ; Jampol LM; Goldberg MF; Frenkel M; Fiscella RG
    Arch Ophthalmol; 1983 Jul; 101(7):1031-3. PubMed ID: 6870623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical aminocaproic acid in the treatment of traumatic hyphema.
    Crouch ER; Williams PB; Gray MK; Crouch ER; Chames M
    Arch Ophthalmol; 1997 Sep; 115(9):1106-12. PubMed ID: 9298049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminocaproic acid reduces the risk of secondary hemorrhage in patients with traumatic hyphema.
    Kutner B; Fourman S; Brein K; Hobson S; Mrvos D; Sheppard J; Weisman S
    Arch Ophthalmol; 1987 Feb; 105(2):206-8. PubMed ID: 3813951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminocaproic acid in the treatment of traumatic hyphema.
    Crouch ER; Frenkel M
    Am J Ophthalmol; 1976 Mar; 81(3):355-60. PubMed ID: 769560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of aminocaproic acid for managing traumatic hyphema in children.
    Teboul BK; Jacob JL; Barsoum-Homsy M; Brunette I; Chevrette L; Milot J; Orquin J; Polomeno RC; Quigley MG
    Ophthalmology; 1995 Nov; 102(11):1646-53. PubMed ID: 9098257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of two dose regimens of epsilon aminocaproic acid in the prevention and management of secondary traumatic hyphemas.
    Palmer DJ; Goldberg MF; Frenkel M; Fiscella R; Anderson RJ
    Ophthalmology; 1986 Jan; 93(1):102-8. PubMed ID: 3951807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of traumatic hyphema with topical epsilon-aminocaproic acid.
    Goldberg MF
    Arch Ophthalmol; 1997 Sep; 115(9):1189-90. PubMed ID: 9298063
    [No Abstract]   [Full Text] [Related]  

  • 8. Traumatic hyphema in children. Treatment with epsilon-aminocaproic acid.
    Kraft SP; Christianson MD; Crawford JS; Wagman RD; Antoszyk JH
    Ophthalmology; 1987 Oct; 94(10):1232-7. PubMed ID: 3317180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of traumatic hyphema in children. An analysis of 340 cases.
    Uusitalo RJ; Ranta-Kemppainen L; Tarkkanen A
    Arch Ophthalmol; 1988 Sep; 106(9):1207-9. PubMed ID: 3415544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical aminocaproic acid significantly reduces the incidence of secondary hemorrhage in traumatic hyphema in the rabbit model.
    Allingham RR; Crouch ER; Williams PB; Catlin JC; Loewy DM; Jacobson J
    Arch Ophthalmol; 1988 Oct; 106(10):1436-8. PubMed ID: 3178555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminocaproic acid versus prednisone for the treatment of traumatic hyphema. A randomized clinical trial.
    Farber MD; Fiscella R; Goldberg MF
    Ophthalmology; 1991 Mar; 98(3):279-86. PubMed ID: 2023746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase III, multicenter, randomized, placebo-controlled clinical trial of topical aminocaproic acid (Caprogel) in the management of traumatic hyphema.
    Pieramici DJ; Goldberg MF; Melia M; Fekrat S; Bradford CA; Faulkner A; Juzych M; Parker JS; McLeod SD; Rosen R; Santander SH
    Ophthalmology; 2003 Nov; 110(11):2106-12. PubMed ID: 14597516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical aminocaproic acid to prevent rebleeding in cases of traumatic hyphema.
    Karkhaneh R; Naeeni M; Chams H; Abdollahi M; Mansouri MR
    Eur J Ophthalmol; 2003; 13(1):57-61. PubMed ID: 12635675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of risk for secondary hemorrhage in traumatic hyphema.
    Rahmani B; Jahadi HR; Rajaeefard A
    Ophthalmology; 1999 Feb; 106(2):380-5. PubMed ID: 9951494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of tranexamic acid and prednisolone in the treatment of traumatic hyphema. A randomized clinical trial.
    Rahmani B; Jahadi HR
    Ophthalmology; 1999 Feb; 106(2):375-9. PubMed ID: 9951493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifibrinolytic agents in the management of traumatic hyphema.
    Goldberg MF
    Arch Ophthalmol; 1983 Jul; 101(7):1029-30. PubMed ID: 6347147
    [No Abstract]   [Full Text] [Related]  

  • 17. Secondary hemorrhage in traumatic hyphema.
    Volpe NJ; Larrison WI; Hersh PS; Kim T; Shingleton BJ
    Am J Ophthalmol; 1991 Nov; 112(5):507-13. PubMed ID: 1951586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent bleeding following traumatic hyphema due to mild hemophilia B (Christmas disease).
    Wilker SC; Singh A; Ellis FJ
    J AAPOS; 2007 Dec; 11(6):622-3. PubMed ID: 17720569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral administration of tranexamic acid in the management of traumatic hyphema in children.
    Deans R; Noël LP; Clarke WN
    Can J Ophthalmol; 1992 Jun; 27(4):181-3. PubMed ID: 1633590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sickle cell trait as a risk factor for secondary hemorrhage in children with traumatic hyphema.
    Nasrullah A; Kerr NC
    Am J Ophthalmol; 1997 Jun; 123(6):783-90. PubMed ID: 9535622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.